Matches in Wikidata for { <http://www.wikidata.org/entity/Q92415609> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q92415609 description "article scientifique publié en 2019" @default.
- Q92415609 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q92415609 description "scientific article published on 16 March 2019" @default.
- Q92415609 description "wetenschappelijk artikel" @default.
- Q92415609 description "наукова стаття, опублікована 16 березня 2019" @default.
- Q92415609 name "Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?" @default.
- Q92415609 name "Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?" @default.
- Q92415609 type Item @default.
- Q92415609 label "Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?" @default.
- Q92415609 label "Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?" @default.
- Q92415609 prefLabel "Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?" @default.
- Q92415609 prefLabel "Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?" @default.
- Q92415609 P1433 Q92415609-E7D6BEE5-584F-4A1E-A821-E3825BC5D427 @default.
- Q92415609 P1476 Q92415609-2D4DC124-CB51-4AF3-B924-3037C5E401C5 @default.
- Q92415609 P2093 Q92415609-2BA04A11-48B8-4204-9EE9-E878E979D8EF @default.
- Q92415609 P2093 Q92415609-B8972E3F-ABAD-4AF2-9314-61A5FF405F58 @default.
- Q92415609 P2093 Q92415609-CF0B8A78-F74D-4310-BEC1-D136B7DFAA4C @default.
- Q92415609 P304 Q92415609-A5452CEE-503B-41A8-B219-EFD958204D84 @default.
- Q92415609 P31 Q92415609-A686F7CE-BC38-45E9-AFB1-19BDF2DC36E2 @default.
- Q92415609 P356 Q92415609-484316FD-6D55-496D-97C2-E06F99411417 @default.
- Q92415609 P433 Q92415609-42E5C6DE-6082-4A12-9BA4-231FBA5006EF @default.
- Q92415609 P478 Q92415609-A4F427D6-8C29-419A-8BC7-C972E156A8C3 @default.
- Q92415609 P50 Q92415609-A2885055-C54F-4AD6-8CB6-5FF3A7C0805A @default.
- Q92415609 P577 Q92415609-60D4CAEB-2C82-447E-9759-CC46B4A71F8A @default.
- Q92415609 P698 Q92415609-7C72DEE8-0BF2-4A01-8ADC-CA24C12E78A5 @default.
- Q92415609 P921 Q92415609-5E48B1A0-2570-44F5-8B4D-BEF1856C6593 @default.
- Q92415609 P356 S10637-019-00760-0 @default.
- Q92415609 P698 30879152 @default.
- Q92415609 P1433 Q2312231 @default.
- Q92415609 P1476 "Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?" @default.
- Q92415609 P2093 "Maria Grazia Rodriquenz" @default.
- Q92415609 P2093 "Navid Sohbani" @default.
- Q92415609 P2093 "Roberto Petrioli" @default.
- Q92415609 P304 "1274-1288" @default.
- Q92415609 P31 Q13442814 @default.
- Q92415609 P356 "10.1007/S10637-019-00760-0" @default.
- Q92415609 P433 "6" @default.
- Q92415609 P478 "37" @default.
- Q92415609 P50 Q41428812 @default.
- Q92415609 P577 "2019-03-16T00:00:00Z" @default.
- Q92415609 P698 "30879152" @default.
- Q92415609 P921 Q1148337 @default.